NCT01878643View on ClinicalTrials.gov

Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

Respiratory InfectionBacterial ResistanceRespiratory Failure

Interventions

DRUG

vancomycin or gentamicin

Choice of antibiotic is determined by Gram stain of sputum.The antibiotic is administered via nebulization through the ventilator circuit every 8 hours

DRUG

Placebo

normal saline administered to patient via nebulization

Trial Locations (1)

11794

University Hospital Medical Center, Stony Brook

All Listed Sponsors

lead

Stony Brook University

OTHER

NCT01878643 - Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit | Biotech Hunter | Biotech Hunter